Jonathan Zontag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan Zontag has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nir Zontag
Arrow Project for Medical Research, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel
2 shared publications - Ron Skorochod
Department of Plastic, Reconstructive and Aesthetic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel
2 shared publications - Yoram Wolf
Unit of plastic and reconstructive surgery, Hillel Yaffe Medical Center, Hadera, Israel
2 shared publications Maya Korem
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication- Nir Hirshoren
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication Nir Zontag
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication
Latest Publications
- 23 April 2026
- Published by SAGE Publications in Surgical Infections
- Vol. 27 (9) , 603-609
Association of Recent Antibiotic Therapy on Post-Thyroidectomy Wound Complications
Background: To assess the association between antibiotic use, for any indication, within 30 days prior to thyroidectomy and the incidence of surgical site infections (SSIs) using a large global electronic medical records database. Methods: A retrospective cohort study was conducted using the TriNetX Global Collaborative Network. Adults who underwent thyroidectomy were stratified into two groups: those who received antibiotics within 30 days prior to the surgical procedure and those who did not. Propensity score matching (PSM) was employed to adjust for demographic and clinical variables. The primary outcome was the development of SSIs up to 90 days following the surgical procedure. Secondary outcomes included wound dehiscence, emergency department (ED) visits, and the use of post-operative antibiotics. Results: After 1:1 PSM, each cohort consisted of 3,518 patients. At 30 days following thyroidectomy, patients who received antibiotics prior to the surgical procedure exhibited significantly higher risks of SSI (risk ratio [RR] 1.75, 95% confidence interval [CI]: 1.136–2.695), wound dehiscence (RR 2.571, 95% CI: 1.389–4.759), ED visits (RR 1.367, 95% CI: 1.126–1.661), and post-operative antibiotic use (RR 4.205, 95% CI: 3.702–4.775) compared to patients without pre-operative antibiotic exposure. These elevated risks were also observed at 60 and 90 days post-surgical procedure. Conclusion: Exposure to pre-surgical antibiotics, for any reason, is associated with post-thyroidectomy complications for at least 90 days. This finding should be considered in the decision-making process regarding the timing of the surgical procedure, particularly for elective, non-urgent procedures such as thyroidectomy.
- 23 April 2026
- Published by SAGE Publications in Surgical Infections
- Vol. 27 (9) , 603-609
Association of Recent Antibiotic Therapy on Post-Thyroidectomy Wound Complications
Background: To assess the association between antibiotic use, for any indication, within 30 days prior to thyroidectomy and the incidence of surgical site infections (SSIs) using a large global electronic medical records database. Methods: A retrospective cohort study was conducted using the TriNetX Global Collaborative Network. Adults who underwent thyroidectomy were stratified into two groups: those who received antibiotics within 30 days prior to the surgical procedure and those who did not. Propensity score matching (PSM) was employed to adjust for demographic and clinical variables. The primary outcome was the development of SSIs up to 90 days following the surgical procedure. Secondary outcomes included wound dehiscence, emergency department (ED) visits, and the use of post-operative antibiotics. Results: After 1:1 PSM, each cohort consisted of 3,518 patients. At 30 days following thyroidectomy, patients who received antibiotics prior to the surgical procedure exhibited significantly higher risks of SSI (risk ratio [RR] 1.75, 95% confidence interval [CI]: 1.136–2.695), wound dehiscence (RR 2.571, 95% CI: 1.389–4.759), ED visits (RR 1.367, 95% CI: 1.126–1.661), and post-operative antibiotic use (RR 4.205, 95% CI: 3.702–4.775) compared to patients without pre-operative antibiotic exposure. These elevated risks were also observed at 60 and 90 days post-surgical procedure. Conclusion: Exposure to pre-surgical antibiotics, for any reason, is associated with post-thyroidectomy complications for at least 90 days. This finding should be considered in the decision-making process regarding the timing of the surgical procedure, particularly for elective, non-urgent procedures such as thyroidectomy.
- Open Access
- 14 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag129
Association Between Proton Pump Inhibitor Use and Short-Term Postoperative Complications Following Abdominoplasty: A Multi-Institutional Cohort Study
Background: Abdominoplasty is a common procedure, especially among patients with obesity, a group in which proton pump inhibitor (PPI) use is highly prevalent. Although there are growing concerns regarding PPI-related complications, there is a lack of data on their effects in aesthetic surgery. Objectives: This study aims to assess the association between preoperative use of PPIs and the risk of short-term postoperative complications after abdominoplasty. Methods: This multicenter cohort study used the TriNetX Global Collaborative Network. Individuals aged 18 years or older who had abdominoplasty were identified and categorized into 2 groups based on preoperative PPI exposure: patients with a documented prescription before surgery and those without any recorded history of PPI prescription. To reduce baseline differences between groups, propensity score matching was conducted to achieve balance in demographic and clinical characteristics. Postoperative outcomes focused on complication rates evaluated at 30, 60, and 90 days after surgery. Results: After 1:1 propensity score matching, both groups comprised 2031 patients each. At 30 days following abdominoplasty, patients who received PPIs before surgery exhibited significantly higher risks of surgical-site infections (risk ratio [RR] 2.467; 95% CI, 1.358-4.48), wound dehiscence (RR 2; 95% CI, 1.079-3.706), opioid prescription (RR 1.368; 95% CI, 1.269-1.475), and any surgical-site complications (RR 2.545; 95% CI, 1.806-3.588) compared with the control group. These risks persisted at 60 and 90 days postsurgery. Conclusions: Preoperative exposure to PPIs may increase the risk of short-term postoperative complications following abdominoplasty. Additional studies are needed to define clinical guidelines regarding the perioperative management of these medications. Level of Evidence:3 (Therapeutic):
- 14 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag129
Open AccessAssociation Between Proton Pump Inhibitor Use and Short-Term Postoperative Complications Following Abdominoplasty: A Multi-Institutional Cohort Study
Background: Abdominoplasty is a common procedure, especially among patients with obesity, a group in which proton pump inhibitor (PPI) use is highly prevalent. Although there are growing concerns regarding PPI-related complications, there is a lack of data on their effects in aesthetic surgery. Objectives: This study aims to assess the association between preoperative use of PPIs and the risk of short-term postoperative complications after abdominoplasty. Methods: This multicenter cohort study used the TriNetX Global Collaborative Network. Individuals aged 18 years or older who had abdominoplasty were identified and categorized into 2 groups based on preoperative PPI exposure: patients with a documented prescription before surgery and those without any recorded history of PPI prescription. To reduce baseline differences between groups, propensity score matching was conducted to achieve balance in demographic and clinical characteristics. Postoperative outcomes focused on complication rates evaluated at 30, 60, and 90 days after surgery. Results: After 1:1 propensity score matching, both groups comprised 2031 patients each. At 30 days following abdominoplasty, patients who received PPIs before surgery exhibited significantly higher risks of surgical-site infections (risk ratio [RR] 2.467; 95% CI, 1.358-4.48), wound dehiscence (RR 2; 95% CI, 1.079-3.706), opioid prescription (RR 1.368; 95% CI, 1.269-1.475), and any surgical-site complications (RR 2.545; 95% CI, 1.806-3.588) compared with the control group. These risks persisted at 60 and 90 days postsurgery. Conclusions: Preoperative exposure to PPIs may increase the risk of short-term postoperative complications following abdominoplasty. Additional studies are needed to define clinical guidelines regarding the perioperative management of these medications. Level of Evidence:3 (Therapeutic):